Delivered by MTPConnect, the Australian Government's $45 million BioMedTech Horizons program, is an Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
The BMTH program currently funds 41 projects and investments from the program are focused on funding proof-of-concept to commercial development of biomedical and medical technologies (biomedtech).
These are the areas for BMTH3.0, for funding of up to $1 million available for medical device projects targeting innovative solutions to address unmet clinical needs in three key focus areas:
- Digitally enabled medical devices in mobile health, health information technology, wearable devices, telehealth and telemedicine, and digitally enabled personalised medicine
- Digitally enabled implantable medical devices addressing unmet needs in any therapeutic area
- General medical devices in the areas of regenerative medicine, women’s health, cardiovascular, orthopaedics, neuroscience, general surgery and oncology
Contact Senior Director BioMedTech Horizons Dr Gerard Gibbs for more information.
To view the projects from Rounds 1, 2 & 3, expand the right menu.